Digenic Inheritance of PROKR2 and WDR11 Mutations in Pituitary Stalk Interruption Syndrome

J Clin Endocrinol Metab. 2017 Jul 1;102(7):2501-2507. doi: 10.1210/jc.2017-00332.

Abstract

Context: Pituitary stalk interruption syndrome (PSIS, ORPHA95496) is a congenital defect of the pituitary gland characterized by the triad of a very thin/interrupted pituitary stalk, an ectopic (or absent) posterior pituitary gland, and hypoplasia or aplasia of the anterior pituitary gland. Complex genetic patterns of inheritance of this disorder are increasingly recognized.

Objective: The objective of this study was to identify a genetic cause of PSIS in an affected child.

Methods: Whole exome sequencing (WES) was performed by using standard techniques, with prioritized genetic variants confirmed via Sanger sequencing. To investigate the effects of one candidate variant on mutant WDR11 function, Western blotting and coimmunofluorescence were used to assess binding capacity, and leptomycin B exposure along with immunofluorescence was used to assess nuclear localization.

Results: We describe a child who presented in infancy with combined pituitary hormone deficiencies and whose brain imaging demonstrated a small anterior pituitary, ectopic posterior pituitary, and a thin, interrupted stalk. WES demonstrated heterozygous missense mutations in two genes required for pituitary development, a known loss-of-function mutation in PROKR2 (c.253C>T;p.R85C) inherited from an unaffected mother, and a WDR11 (c.1306A>G;p.I436V) mutation inherited from an unaffected father. Mutant WDR11 loses its capacity to bind to its functional partner, EMX1, and to localize to the nucleus.

Conclusions: WES in a child with PSIS and his unaffected family implicates a digenic mechanism of inheritance. In cases of hypopituitarism in which there is incomplete segregation of a monogenic genotype with the phenotype, the possibility that a second genetic locus is involved should be considered.

Publication types

  • Case Reports
  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Exome / genetics
  • Genetic Predisposition to Disease*
  • Genotype
  • Heterozygote
  • Humans
  • Hypopituitarism / congenital
  • Hypopituitarism / genetics*
  • Hypopituitarism / pathology
  • Infant, Newborn
  • Male
  • Membrane Proteins / genetics*
  • Mutation*
  • Pedigree
  • Pituitary Gland / abnormalities*
  • Proto-Oncogene Proteins / genetics*
  • Receptors, G-Protein-Coupled / genetics*
  • Receptors, Peptide / genetics*
  • Syndrome

Substances

  • Membrane Proteins
  • PROKR2 protein, human
  • Proto-Oncogene Proteins
  • Receptors, G-Protein-Coupled
  • Receptors, Peptide
  • WDR11 protein, human